News

Technology News

Pappas Ventures Closes Fourth Life Science Fund

Wednesday, March 11, 2009 5:12:00 AM PDT | VentureDeal Staff
Research Triangle Park, North Carolina  --  Venture capital firm Pappas Ventures announced the closing of its fourth venture capital fund.

Pappas Ventures IV is a $102 million fund that will focus on product oriented biopharmaceutical companies and secondarily on medical technologies.

“We are very pleased to have reached this important milestone,” said Eric W. Linsley, a partner at Pappas Ventures. “The new fund speaks to the strong support we have received from our investors – both new and old – and the track record that our firm has built over the past 15 years.”

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1